Intellia slashes workforce by 27% to focus on late stage CRISPR candidates
Pharmaceutical Technology
JANUARY 12, 2025
Intellia expects to incur charges of $8m associated with the reorganisation, which will likely be incurred in Q1 2025.
Pharmaceutical Technology
JANUARY 12, 2025
Intellia expects to incur charges of $8m associated with the reorganisation, which will likely be incurred in Q1 2025.
Bio Pharma Dive
JANUARY 12, 2025
The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat chronic hepatitis B infections.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
JAMA Internal Medicine
JANUARY 12, 2025
This systematic review and network meta-analysis evaluates the effectiveness and safety of antiviral treatment for patients with nonsevere influenza and thus support an update of World Health Organization guidelines on antiviral treatment for influenza.
FDA Law Blog
JANUARY 12, 2025
By Charles G. Raver & James E. Valentine & Ellis Unger & Frank J. Sasinowski On December 5, 2024, FDA published a new draft guidance on accelerated approval providing a much needed and substantial update to its guidance on the pathway. FDAs application and use of accelerated approval has evolved dramatically since it was first developed by the Agency to help address the HIV/AIDS epidemic in the late 1980s.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
JAMA Internal Medicine
JANUARY 12, 2025
This Viewpoint discusses the concept of skin failure, the breakdown of skin in aging and critically ill patients; how it differs from pressure injury; and future areas of research regarding the process.
Let's personalize your content